The overactive bladder

Therapeutic Advances in Urology

Volumn 2, Issue 4, 2010, Pages 147-155

  Foon, Richard ^a   Drake, Marcus J ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

detrusor overactivity; overactive bladder; urge incontinence; urgency

Indexed keywords

BOTULINUM TOXIN A; DARIFENACIN; FESOTERODINE; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PROPIVERINE; SOLIFENACIN; TROSPIUM CHLORIDE;

BLADDER RECONSTRUCTION; BLADDER TRAINING; CENTRAL NERVOUS SYSTEM; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CLINICAL EXAMINATION; DETRUSOR MUSCLE; DETRUSOR MYECTOMY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; ECHOGRAPHY; FLUID INTAKE; HUMAN; INNERVATION; LEYDIG CELL; MEDICAL HISTORY; MICTURITION; MUSCLE CELL; MUSCLE RESECTION; NERVE STIMULATION; NEUROLOGIC EXAMINATION; NONHUMAN; OVERACTIVE BLADDER; PERIPHERAL NERVE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; URINARY DIVERSION; URINE INCONTINENCE; UROTHELIUM;

EID: 79551690972     PISSN: 17562872     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756287210373757     Document Type: Review

References (92)

1. Abrams, P., Andersson, K.E., Birder, L., Brubaker, L., Cardozo, L., Chapple, C. et al. (2010) Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 29: 213-240.
2. Abrams, P., Avery, K., Gardener, N. and Donovan, J. (2006a) The International Consultation on Incontinence Modular Questionnaire: www.iciq.net. J Urol 175: 1063-1066.
3. Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U. et al. (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21: 167-178.
4. Abrams, P., Kaplan, S., De Koning Gans, H.J. and Millard, R. (2006b) Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 175: 999-1004.
5. Abrams, P. and Klevmark, B. (1996) Frequency volume charts: an indispensable part of lower urinary tract assessment. Scand J Urol Nephrol Suppl 179: 47-53.
6. An, J.Y., Yun, H.S., Lee, Y.P., Yang, S.J., Shim, J.O., Jeong, J.H. et al. (2002) The intracellular pathway of the acetylcholine-induced contraction in cat detrusor muscle cells. Br J Pharmacol 137: 1001-1010.
7. Andersson, K.E., Uckert, S., Stief, C. and Hedlund, P. (2007) Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS. Neurourol Urodyn 26: 928-933.
8. Apostolidis, A., Dasgupta, P., Denys, P., Elneil, S., Fowler, C.J., Giannantoni, A. et al. (2009) Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 55: 100-119.
9. Apostolidis, A., Jacques, T.S., Freeman, A., Kalsi, V., Popat, R., Gonzales, G. et al. (2008) Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol 53: 1245-1253.
10. Apostolidis, A., Popat, R., Yiangou, Y., Cockayne, D., Ford, A.P., Davis, J.B. et al. (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174: 977-982.
11. Araki, I., Du, S., Kobayashi, H., Sawada, N., Mochizuki, T., Zakoji, H. et al. (2008) Roles of mechanosensitive ion channels in bladder sensory transduction and overactive bladder. Int J Urol 15: 681-687.
12. Bang, L.M., Easthope, S.E. and Perry, C.M. (2003) Transdermal oxybutynin: for overactive bladder. Drugs Aging 20: 857-864.
13. Basra, R. and Kelleher, C. (2007) Disease burden of overactive bladder: quality-of-life data assessed using ICI-recommended instruments. Pharmacoeconomics 25: 129-142.
14. Brading, A.F. (1997) A myogenic basis for the overactive bladder. Urology 50(6A Suppl): 57-67.
15. Brading, A.F. (2006) Spontaneous activity of lower urinary tract smooth muscles: correlation between ion channels and tissue function. J Physiol 570: 13-22.
16. Brading, A.F. and Turner, W.H. (1994) The unstable bladder: towards a common mechanism. Br J Urol 73: 3-8.
17. Bristow, S.E. and Neal, D.E. (1996) Ambulatory urodynamics. Br J Urol 77: 333-338.
18. Brubaker, L., Richter, H.E., Visco, A., Mahajan, S., Nygaard, I., Braun, T.M. et al. (2008) Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol 180: 217-222.
19. Cardozo, L. (2007) The overactive bladder syndrome: treating patients on an individual basis. BJU Int 99(Suppl 3): 1-7.
20. Cespedes, R.D., Cross, C.A. and McGuire, E.J. (1996) Modified Ingelman-Sundberg bladder denervation procedure for intractable urge incontinence. J Urol 156: 1744-1747.
21. Chancellor, M.B., Fowler, C.J., Apostolidis, A., de Groat, W.C., Smith, C.P., Somogyi, G.T. et al. (2008a) Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. Nat Clin Pract Urol 5: 319-328.
22. Chancellor, M.B., Zinner, N., Whitmore, K., Kobashi, K., Snyder, J.A., Siami, P. et al. (2008b) Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study. Clin Ther 30: 1766-1781.
23. Chapple, C.R. and Bryan, N.P. (1998) Surgery for detrusor overactivity. World J Urol 16: 268-273.
24. Chapple, C.R., Hampson, S.J., Turner-Warwick, R.T. and Worth, P.H. (1991) Subtrigonal phenol injection How safe and effective is it? Br J Urol 68: 483-486.
25. Chopra, B., Gever, J., Barrick, S.R., Hanna-Mitchell, A.T., Beckel, J.M., Ford, A.P. et al. (2008) Expression and function of rat urothelial P2Y receptors. Am J Physiol Renal Physiol 294: F821-F829.
26. Chou, E.C., Capello, S.A., Levin, R.M. and Longhurst, P.A. (2003) Excitatory alpha1-adrenergic receptors predominate over inhibitory beta-receptors in rabbit dorsal detrusor. J Urol 170: 2503-2507.
27. Coyne, K.S., Sexton, C.C., Irwin, D.E., Kopp, Z.S., Kelleher, C.J. and Milsom, I. (2008) The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 101: 1388-1395.
28. Coyne, K.S., Sexton, C.C., Thompson, C.L., Milsom, I., Irwin, D., Kopp, Z.S. et al. (2009) The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int 104: 352-360.
29. Daneshgari, F. and Abrams, P. (2005) Future directions in pelvic neuromodulation. Urol Clin North Am 32: 113-115, viii.
30. de Groat, W.C. (1997) A neurologic basis for the overactive bladder. Urology 50(6A Suppl): 36-52, available from: PM:9426749.
31. de Groat, W.C. (2006) Integrative control of the lower urinary tract: preclinical perspective. Br J Pharmacol 147(Suppl 2): S25-S40.
32. de Jongh, R., van Koeveringe, G.A., van Kerrebroeck, P.E., Markerink-van, I.M., de, V.J. and Gillespie, J.I. (2007) The effects of exogenous prostaglandins and the identification of constitutive cyclooxygenase I and II immunoreactivity in the normal guinea pig bladder. BJU Int 100: 419-429.
33. de Jongh, R., Vranken, J., Vundelinckx, G., Bosmans, E., Maes, M. and Heylen, R. (1997) The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor. Cytokine 9: 696-701.
34. de Ridder, D., Chandiramani, V., Dasgupta, P., Van Poppel, H., Baert, L. and Fowler, C.J. (1997) Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup. J Urol 158: 2087-2092.
35. Drake, M.J. (2007) The integrative physiology of the bladder. Ann R Coll Surg Engl 89: 580-585.
36. Drake, M.J., Fowler, C.J., Griffiths, D., Mayer, E., Paton, J.F. and Birder, L. (2010) Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms. Neurourol Urodyn 29: 119-127.
37. Drake, M.J., Fry, C.H. and Eyden, B. (2006) Structural characterization of myofibroblasts in the bladder. BJU Int 97: 29-32.
38. Drake, M.J., Hedlund, P., Mills, I.W., McCoy, R., McMurray, G., Gardner, B.P. et al. (2000) Structural and functional denervation of human detrusor after spinal cord injury. Lab Invest 80: 1491-1499.
39. Drake, M.J., Mills, I.W. and Gillespie, J.I. (2001) Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function. Lancet 358: 401-403.
40. Duthie, J., Wilson, D.I., Herbison, G.P. and Wilson, D. (2007) Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev 3: CD005493.
41. Fowler, C.J. and Griffiths, D.J. (2010) A decade of functional brain imaging applied to bladder control. Neurourol Urodyn 29: 49-55.
42. Frazier, E.P., Peters, S.L., Braverman, A.S., Ruggieri Sr, M.R. and Michel, M.C. (2008) Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 377: 449-462.
43. Fry, C.H., Ikeda, Y., Harvey, R., Wu, C. and Sui, G.P. (2004) Control of bladder function by peripheral nerves: avenues for novel drug targets. Urology 63(3 Suppl 1): 24-31.
44. Fry, C.H., Sui, G.P., Kanai, A.J. and Wu, C. (2007) The function of suburothelial myofibroblasts in the bladder. Neurourol Urodyn 26: 914-919.
45. Gevaert, T., Vriens, J., Segal, A., Everaerts, W., Roskams, T., Talavera, K. et al. (2007) Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest 117: 3453-3462.
46. Hasan, S.T., Marshall, C., Robson, W.A. and Neal, D.E. (1995a) Clinical outcome and quality of life following enterocystoplasty for idiopathic detrusor instability and neurogenic bladder dysfunction. Br J Urol 76: 551-557.
47. Hasan, S.T., Robson, W.A., Ramsden, P.D., Essenhigh, D.M. and Neal, D.E. (1995b) Outcome of endoscopic bladder transection. Br J Urol 75: 592-596.
48. Hashim, H. and Abrams, P. (2006) Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 175: 191-194.
49. Hashitani, H., Yanai, Y. and Suzuki, H. (2004) Role of interstitial cells and gap junctions in the transmission of spontaneous Ca2+ signals in detrusor smooth muscles of the guinea-pig urinary bladder. J Physiol 559: 567-581.
50. Hay-Smith, E.J. and Dumoulin, C. (2006) Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 1: CD005654.
51. Hayn, M.H., Ballesteros, I., de Miguel, F., Coyle, C.H., Tyagi, S., Yoshimura, N. et al. (2008) Functional and immunohistochemical characterization of CB1 and CB2 receptors in rat bladder. Urology 72: 1174-1178.
52. Hicks, A., McCafferty, G.P., Riedel, E., Aiyar, N., Pullen, M., Evans, C. et al. (2007) GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog. J Pharmacol Exp Ther 323: 202-209.
53. Irwin, D.E., Milsom, I., Hunskaar, S., Reilly, K., Kopp, Z., Herschorn, S. et al. (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50: 1306-1314.
54. Irwin, D.E., Milsom, I., Kopp, Z. and Abrams, P. (2008) Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol 53: 1029-1037.
55. Jiang, C., Yang, H., Fu, X., Qu, S. and Lindstrom, S. (2008) Bladder cooling reflex and external urethral sphincter activity in the anesthetized and awake guinea pig. Pflugers Arch 457: 61-66.
56. Kaiho, Y., Nishiguchi, J., Kwon, D.D., Chancellor, M.B., Arai, Y., Snyder, P.B. et al. (2008) The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction. BJU Int 101: 615-620.
57. Kato, K., Furuhashi, K., Suzuki, K., Murase, T., Sato, E. and Gotoh, M. (2007) Overactive bladder and glaucoma: a survey at outpatient clinics in Japan. Int J Urol 14: 595-597.
58. Kessler, T.M., Burkhard, F.C., Madersbacher, H., Kofler, A., Poewe, W. and Kiss, G. (2008) Safety of prolonged sacral neuromodulation tined lead testing. Curr Med Res Opin 24: 343-347.
59. Khera, M., Somogyi, G.T., Kiss, S., Boone, T.B. and Smith, C.P. (2004) Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 45: 987-993.
60. Khullar, V., Rovner, E.S., Dmochowski, R., Nitti, V., Wang, J. and Guan, Z. (2008) Fesoterodine dose response in subjects with overactive bladder syndrome. Urology 71: 839-843.
61. Kumar, S.P. and Abrams, P.H. (2005) Detrusor myectomy: long-term results with a minimum followup of 2 years. BJU Int 96: 341-344.
62. Lagou, M., Drake, M.J., Markerink Van Ittersum, M., de Vente, J. and Gillespie, J.I. (2006) Interstitial cells and phasic activity in the isolated mouse bladder. BJU Int 98: 643-650.
63. Lazzeri, M., Spinelli, M., Zanollo, A. and Turini, D. (2004) Intravesical vanilloids and neurogenic incontinence: ten years experience. Urol Int 72: 145-149.
64. Madersbacher, H. (2000) Denervation techniques. BJU Int 85(Suppl 3): 1-6.
65. McCloskey, K.D. (2010) Interstitial cells in the urinary bladder-localization and function. Neurourol Urodyn 29: 82-87.
66. Mills, I.W., Greenland, J.E., McMurray, G., McCoy, R., Ho, K.M., Noble, J.G. et al. (2000) Studies of the pathophysiology of idiopathic detrusor instability: the physiological properties of the detrusor smooth muscle and its pattern of innervation. J Urol 163: 646-651.
67. Mukerji, G., Yiangou, Y., Corcoran, S.L., Selmer, I.S., Smith, G.D., Benham, C.D. et al. (2006) Cool and menthol receptor TRPM8 in human urinary bladder disorders and clinical correlations. BMC Urol 6: 6.
68. Otsuka, A., Shinbo, H., Matsumoto, R., Kurita, Y. and Ozono, S. (2008) Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium. Naunyn Schmiedebergs Arch Pharmacol 377: 473-481.
69. Ouslander, J.G., Shih, Y.T., Malone-Lee, J. and Luber, K. (2000) Overactive bladder: special considerations in the geriatric population. Am J Manag Care 6(11 Suppl): S599-S606.
70. Pengelly, A.W., Stephenson, T.P., Milroy, E.J., Whiteside, C.G. and Turner-Warwick, R. (1978) Results of prolonged bladder distension as treatment for detrusor instability. Br J Urol 50: 243-245.
71. Peters, K.M., Killinger, K.A., Boguslawski, B.M. and Boura, J.A. (2009) Chronic pudendal neuromodulation: Expanding available treatment options for refractory urologic symptoms. Neurourol Urodyn [Epub ahead of print].
72. Reeves, P., Irwin, D., Kelleher, C., Milsom, I., Kopp, Z., Calvert, N. et al. (2006) The current and future burden and cost of overactive bladder in five European countries. Eur Urol 50: 1050-1057.
73. Reitz, A., Gobeaux, N., Mozer, P., Delmas, V., Richard, F. and Chartier-Kastler, E. (2007) Topographic anatomy of a new posterior approach to the pudendal nerve for stimulation. Eur Urol 51: 1350-1355.
74. Roosen, A., Datta, S.N., Chowdhury, R.A., Patel, P.M., Kalsi, V., Elneil, S. et al. (2009) Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment. Eur Urol 55: 1440-1448.
75. Roxburgh, C., Cook, J. and Dublin, N. (2007) Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. Cochrane Database Syst Rev 4: CD003190.
76. Schmid, D.M., Sauermann, P., Werner, M., Schuessler, B., Blick, N., Muentener, M. et al. (2006) Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176: 177-185.
77. Schurch, B., Schmid, D.M. and Stohrer, M. (2000) Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 342: 665.
78. Shaban, A.M. and Drake, M.J. (2008) Botulinum toxin treatment for overactive bladder: risk of urinary retention. Curr Urol Rep 9: 445-451.
79. Starkman, J.S. and Dmochowski, R.R. (2008) Urgency assessment in the evaluation of overactive bladder (OAB). Neurourol Urodyn 27: 13-21.
80. Staskin, D.R., Dmochowski, R.R., Sand, P.K., Macdiarmid, S.A., Caramelli, K.E., Thomas, H. et al. (2009) Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study. J Urol 181: 1764-1772.
81. Stewart, W.F., Van Rooyen, J.B., Cundiff, G.W., Abrams, P., Herzog, A.R., Corey, R. et al. (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20: 327-336.
82. Streng, T., Axelsson, H.E., Hedlund, P., Andersson, D.A., Jordt, S.E., Bevan, S. et al. (2008) Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol 53: 391-399.
83. Swami, K.S., Feneley, R.C., Hammonds, J.C. and Abrams, P. (1998) Detrusor myectomy for detrusor overactivity: a minimum 1-year follow-up. Br J Urol 81: 68-72.
84. Swithinbank, L., Hashim, H. and Abrams, P. (2005) The effect of fluid intake on urinary symptoms in women. J Urol 174: 187-189.
85. Tadic, S.D., Griffiths, D., Schaefer, W. and Resnick, N.M. (2008) Abnormal connections in the supraspinal bladder control network in women with urge urinary incontinence. Neuroimage 39: 1647-1653.
86. Takahashi, R., Nishimura, J., Hirano, K., Seki, N., Naito, S. and Kanaide, H. (2004) Ca2+ sensitization in contraction of human bladder smooth muscle. J Urol 172: 748-752.
87. Takasu, T., Ukai, M., Sato, S., Matsui, T., Nagase, I., Maruyama, T. et al. (2007) Effect of (R)-2-(2-aminothiazol-4-yl)-4’-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther 321: 642-647.
88. Takeda, M., Noshiro, R., Onozato, M.L., Tojo, A., Hasannejad, H., Huang, X.L. et al. (2004) Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors. Eur J Pharmacol 483: 133-138.
89. van der Pal, F., van Balken, M.R., Heesakkers, J.P., Debruyne, F.M. and Bemelmans, B.L. (2006) Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary? BJU Int 97: 547-550.
90. Van Kerrebroeck, P.E., van Voskuilen, A.C., Heesakkers, J.P., Nijholt, A.A., Siegel, S., Jonas, U. et al. (2007) Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 178: 2029-2034.
91. Wallace, S.A., Roe, B., Williams, K. and Palmer, M. (2004) Bladder training for urinary incontinence in adults. Cochrane Database Syst Rev 1: CD001308.
92. Yong, S.M., Dublin, N., Pickard, R., Cody, D.J., Neal, D.E. and N–Dow, J. (2003) Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev 1: CD003306.